Observing such a consistently successful trader, it’s no wonder that many investors strive to imitate his strategies in the hope of enjoying substantial long-term profits by following in his footsteps, so to speak.
While Bitcoin’s price surge took a pause after reaching an all-time high, the past week has shown robust positive trends for alternative cryptocurrencies. The Dogecoin token experienced significant growth due to the approval of crypto-related bills in the U.S. House of Representatives and news that Bit Origin plans to incorporate Dogecoin as a key component in its cryptocurrency reserves strategy.
On this fine morn of July 20, our esteemed analyst ShayanMarkets—a name that sings like a choir of crypto prophets—has observed that Bitcoin reserves nestled in the warm embrace of centralized exchanges have swelled to heights we hadn’t seen since the grand spectacle of June 25. What does this signify? It suggests that our beloved investors, those crafty creatures, are engaging in an age-old tradition known as “profit-taking.” How quaint! 🐢✨
And what do we find on the mystical platform of X? None other than the so-called “Titan of Crypto,” a prophet of pixels and charts, declaring Ethereum’s impending breakout. Oh, the drama! The suspense! The charts! 📈
On January 23, 2025, President Trump, in a moment of *clarity* (or perhaps satire), signed an executive order boldly titled “Strengthening American Leadership in Digital Financial Technology.” Quite the mouthful, isn’t it? It was designed to crown the U.S. as the crypto kingpin, trampling Biden’s 2022 crypto subtleties (EO 14067) underfoot, and boldly slamming the door on creating a government-issued digital dollar—because why not add a splash of chaos? 💼🚫
Over the past week, I’ve noticed a significant uptick in BigBear.ai’s valuation, as investors remain optimistic about firms specializing in AI solutions for defense applications. The company’s stock price has soared by an impressive 101% over the last month and 214% within the past three months.
While Bitcoin maintains a stoic posture below $120,000—like a gentleman refusing to dance—altcoins flutter about the ballroom, stealing glances and market share with equal aplomb. Such impertinence!
Three experts from CORP-DEPO believe they’ve found promising stocks that could potentially become ‘monsters’. Here’s their reasoning behind choosing CRISPR Therapeutics (CRSP), Summit Therapeutics (SMMT), and Viking Therapeutics (VKTX).
Businesses and organizations are bolstering their cybersecurity defenses due to the escalating risk of state-backed cyber assaults. Furthermore, there’s a rising trend among both companies and individuals to leverage technology for safeguarding confidential data like banking details, medical history, and personal identification data.
Over the past year up until July 17th, the leading pharmaceutical company has experienced a significant drop of 52%. However, considering the potential for growth, investing in it now could potentially double your investment over the next six years or so. Here’s why this stock is an attractive buy at its current price point.